These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 33743082)

  • 21. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
    Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
    PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussion.
    Jakubowska Z; Malyszko J
    J Nephrol; 2024 Mar; 37(2):267-279. PubMed ID: 37989976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
    Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
    Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of methods for detecting glycemic disorders.
    Bergman M; Abdul-Ghani M; DeFronzo RA; Manco M; Sesti G; Fiorentino TV; Ceriello A; Rhee M; Phillips LS; Chung S; Cravalho C; Jagannathan R; Monnier L; Colette C; Owens D; Bianchi C; Del Prato S; Monteiro MP; Neves JS; Medina JL; Macedo MP; Ribeiro RT; Filipe Raposo J; Dorcely B; Ibrahim N; Buysschaert M
    Diabetes Res Clin Pract; 2020 Jul; 165():108233. PubMed ID: 32497744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of the glycated albumin versus glycosylated hemoglobin in follow-up of glucose homeostasis in hemodialysis-maintained type-2 diabetic patients.
    Ahmed E; El Zahraa Sayed Bokhary F; Ismail S; Mahmoud Abd El Hameed W
    Endocr Regul; 2022 Feb; 56(1):10-21. PubMed ID: 35180823
    [No Abstract]   [Full Text] [Related]  

  • 31. [Insights on glycated albumin].
    Hay-Lombardie A; Kamel S; Bigot-Corbel E
    Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
    Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
    J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
    Mori K; Emoto M; Abe M; Inaba M
    J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.
    Harada K; Sumida K; Yamaguchi Y; Akai Y
    Clin Nephrol; 2014 Aug; 82(2):107-14. PubMed ID: 24985951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glycemic control in patients with diabetes mellitus on hemodialysis].
    Lobanova KG; Severina AS; Martinov SA; Shamkhalova MS; Shestakova MV
    Ter Arkh; 2019 Oct; 91(10):124-134. PubMed ID: 32598642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.